David G. Maloney, MD, PhD, on ALL: New Therapeutic Agents

2017 NCCN Hematologic Malignancies Congress
Tweet this page

David G. Maloney, MD, PhD, of the Fred Hutchinson Cancer Research Center, reviews the clinical data and ongoing trials evaluating immunotherapy in the setting of relapsed or refractory acute lymphocytic leukemia and discusses major adverse events of treatment.

Advertisement

Advertisement



Advertisement